Background and FDAs Announcement FDA's April 1, 2026, update to its compounding policy page follows more than 18 months of regulatory activity surrounding the compounding of GLP-1 medications, primarily semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound)
The Science of Collagen and Blood Pressure Recent research has begun to shed light on how supplemental collagen may actually support those managing high blood pressure
Neuroimage 24, 862873.CrossRefGoogle ScholarPubMed de Luis, DA, Aller, R, Izaola, O and Bachiller, R (2015) Role of rs6923761 gene variant in glucagon-like peptide 1 receptor in basal GLP-1 levels, cardiovascular risk factor and serum adipokine levels in naive type 2 diabetic patients
Pick A Good Spot Inject into a place with some fat, but avoid areas right over veins or scars